Singapore markets closed

Mithra Pharmaceuticals SA (MITPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
6.750.00 (0.00%)
At close: 09:40AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 15.58M
Enterprise value 213.98M
Trailing P/E N/A
Forward P/E 2.20
PEG ratio (5-yr expected) N/A
Price/sales (ttm)13.00
Price/book (mrq)9.76
Enterprise value/revenue 17.57
Enterprise value/EBITDA -5.71

Trading information

Stock price history

Beta (5Y monthly) 0.48
52-week change 30.00%
S&P500 52-week change 326.27%
52-week high 36.75
52-week low 36.75
50-day moving average 36.75
200-day moving average 36.75

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 566.91M
Implied shares outstanding 666.91M
Float 8N/A
% held by insiders 115.64%
% held by institutions 123.13%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-74.78%

Management effectiveness

Return on assets (ttm)-11.14%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)40.16M
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)-40.50%
Gross profit (ttm)N/A
EBITDA -52.77M
Net income avi to common (ttm)-173.5M
Diluted EPS (ttm)-2.21
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.98M
Total cash per share (mrq)N/A
Total debt (mrq)305.45M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.90
Book value per share (mrq)-0.15

Cash flow statement

Operating cash flow (ttm)-2.18M
Levered free cash flow (ttm)-6.59M